6-K 1 dp78956_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July, 2017

 

 

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X 

 

Form 40-F

 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes

 

 

No

X 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes

 

 

No

X

 

 





 

ISRAEL CHEMICALS LTD.

 

 INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 





ISRAEL CHEMICALS LTD.

 

 

1.

Contracts for the Sale of Potash to Customers in China

 

 

 




 

Item 1

 

Contracts for the Sale of Potash to Customers in China

 

 

The Company hereby announces that it has signed several contracts with its customers in China to supply an aggregate 925,000 metric tons of potash for delivery during 2017. The selling prices stipulated in the contracts are in line with the recent contract prices in China. The contracts are part of three-year framework agreements between ICL and its Chinese customers.

 

 





 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Kobi Altman

 

 

 

 

Name:

Kobi Altman

 

 

 

 

Title:

Chief Financial Officer

 

 

 

Israel Chemicals Ltd.

 

 

 

 

 

 

By:

/s/ Lisa Haimovitz

 

 

 

 

Name:

Lisa Haimovitz

 

 

 

 

Title:

Senior Vice President, Global General Counsel and Corporate Secretary

 

Date: July 30, 2017